David Baram - President & CEO @ EmendoBio, Inc.

Overview

Number of Founded Organizations

CB Rank (Person)

David Baram is the President and CEO at Emendo Biotherapeutics. He attended Weizmann Institute of Science.

Number of Current Jobs

Number of Past Jobs

is the

President & CEO

. Additionally,

has had

past job as the

CTO and President

Organization Name	Title At Company	Start Date	End Date
SmartZyme BioPharma	CTO and President	—	Sep 2017

Hub Name	CB Rank (Hub)
Therapeutics Acquired Companies	28,790
Greater New York Area Acquired Companies	4,016
United States Therapeutics Acquired Companies	49,949
Biotechnology Acquired Companies With More Than 50 Employees	9,975
Greater New York Area Acquired Companies With Less Than $500M in Revenue	7,670
Pharmaceutical Acquired Companies With Less Than $10M in Revenue	27,365
East Coast Acquired Companies With Less Than $10M in Revenue	2,440
Biotechnology Acquired Companies With Less Than $500M in Revenue	6,472
Therapeutics Acquired Companies With More Than $1M in Revenue	50,713
Greater New York Area Health Care Acquired Companies	36,171

studied at

There is no recent news or activity for this profile.